These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Hamaguchi K, Godwin AK, Yakushiji M, O'Dwyer PJ, Ozols RF, Hamilton TC. Cancer Res; 1993 Nov 01; 53(21):5225-32. PubMed ID: 8106143 [Abstract] [Full Text] [Related]
11. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells. Slapak CA, Fracasso PM, Martell RL, Toppmeyer DL, Lecerf JM, Levy SB. Cancer Res; 1994 Nov 01; 54(21):5607-13. PubMed ID: 7923205 [Abstract] [Full Text] [Related]
12. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance. Politi PM, Sinha BK. Mol Pharmacol; 1989 Mar 01; 35(3):271-8. PubMed ID: 2564628 [Abstract] [Full Text] [Related]
19. Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells. Keizer HG, Schuurhuis GJ, Broxterman HJ, Lankelma J, Schoonen WG, van Rijn J, Pinedo HM, Joenje H. Cancer Res; 1989 Jun 01; 49(11):2988-93. PubMed ID: 2566376 [Abstract] [Full Text] [Related]
20. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers. Abbaszadegan MR, Cress AE, Futscher BW, Bellamy WT, Dalton WS. Cancer Res; 1996 Dec 01; 56(23):5435-42. PubMed ID: 8968098 [Abstract] [Full Text] [Related] Page: [Next] [New Search]